Cite

HARVARD Citation

    Mesu, V. et al. (2017). Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial. Lancet. 391 (10116), pp. 144-154. [Online]. 
  
Back to record